CDKN2A and endometrial carcinoma: We evaluated whether rs17761446 worked as a cis-regulatory element of ANRIL, CDKN2A, and CDKN2B with the allele specific expression (ASE) analysis using eutopic endometrial tissues and endometrial carcinoma cell lines.